Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Recent Jerini patent describes novel therapeutic agents for eye, skin and joint disorders

Nov. 10, 2005

Novartis signs agreement for glaucoma treatment Y-39983

Nov. 10, 2005

A second phase III study confirms the therapeutic benefits of ranibizumab in AMD

Nov. 9, 2005

OT-551 begins phase II trial in cataract prevention

Nov. 9, 2005

Fovea completes Series A financing to develop drugs for retinal diseases

Nov. 9, 2005

Pegaptanib improves visual acuity in patients with diabetic macular edema

Oct. 27, 2005

Clinical evidence supports the use of Evizon in wet AMD

Oct. 26, 2005

Bevacizumab improves visual acuity of patients with neovascular AMD

Oct. 26, 2005

Method to predict/detect age-related macular degeneration reported by the University of Iowa

Oct. 26, 2005

Infliximab shows promise in the treatment of refractory PUK

Oct. 26, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...